Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JAGX
JAGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JAGX News
Jaguar Health Leverages AI for Crofelemer Treatment Advancement
5d ago
NASDAQ.COM
Jaguar Health Reports Q4 2025 Earnings Highlights
Apr 11 2026
Yahoo Finance
Jaguar Health Completes Study on Chemotherapy-Induced Diarrhea in Dogs
Apr 08 2026
Newsfilter
Jaguar Health Reports Q4 2025 Financial Results
Apr 08 2026
seekingalpha
Jaguar Announces Extension of MVID Clinical Trial
Mar 18 2026
Newsfilter
Life Sciences Virtual Investor Forum Highlights Available On-Demand
Mar 13 2026
Globenewswire
Life Sciences Virtual Investor Forum Agenda Announced
Mar 10 2026
Globenewswire
Jaguar Announces Special Stock Dividend to Protect Shareholders
Mar 02 2026
Yahoo Finance
Jaguar Declares Special Stock Dividend to Protect Shareholders
Feb 18 2026
Yahoo Finance
Rapt Therapeutics Acquired by GSK for $58 per Share, Valuing at $2.2 Billion
Jan 20 2026
Benzinga
Jaguar Health Subsidiary Napo Signs $18 Million Licensing Deal
Jan 16 2026
Benzinga
PainReform Ltd. (PRFX) Announces Name Change, Shares Surge 27.4%
Jan 16 2026
Benzinga
Jaguar Health Extends Conditional Approval for Canalevia-CA1 Until December 2026
Dec 10 2025
Newsfilter
88th Emerging Growth Conference Scheduled for December 10-11, 2025
Dec 10 2025
Globenewswire
Keysight Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Nov 25 2025
Benzinga
Jaguar Health Submits Amended Protocol for Crofelemer Clinical Trial in MVID Patients
Nov 24 2025
Newsfilter
Show More News
